Actively Recruiting

Phase 2
Age: 18Years - 40Years
FEMALE
Healthy Volunteers
ID02647827

Acupuncture or Metformin for Insulin Resistance in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial

Led by Karolinska Institutet · Updated on 2024-10-09

303

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

Sponsors

K

Karolinska Institutet

Lead Sponsor

K

Karolinska University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness of acupuncture compared to metformin, both combined with lifestyle management, in improving glucose control in women with insulin resistance and polycystic ovary syndrome (PCOS). The study aims to see if these treatments improve ovulation, hormone balance, quality of life, and symptoms of anxiety and depression, while also investigating if acupuncture has fewer side effects. They also explore whether these treatments can reverse molecular changes that may help prevent type 2 diabetes. Participants will be randomly assigned to one of three groups: lifestyle management alone, lifestyle management plus acupuncture, or lifestyle management plus metformin. Acupuncture treatments involve inserting sterile needles into specific abdominal and leg acupuncture points related to ovarian and pancreatic function, administered three times weekly for four weeks, then twice weekly for twelve weeks. Metformin is taken orally, starting at a low dose and gradually increasing to 1500 mg daily over 16 weeks. All women receive lifestyle advice on weight management, diet, and exercise at the start. During the study, participants undergo assessments at the start, after 4 months of treatment, and again 4 months post-treatment. These include blood tests measuring insulin sensitivity, glucose levels, hormone levels, and molecular markers from tissue samples. Researchers will also monitor menstrual patterns, ovulation, quality of life, mental health symptoms, eating habits, and treatment side effects. The study lasts 8 months with ongoing evaluations to determine the cost-effectiveness and overall impact of each treatment approach.

CONDITIONS

Brief Title

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Who Can Participate

Age: 18Years - 40Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 to 40 years
  • Body mass index (BMI) between 25 and 40
  • Diagnosed with PCOS according to Rotterdam criteria 2003, with at least two of: clinical signs of hyperandrogenism (hirsutism or acne), oligo/amenorrhea, or polycystic ovaries on ultrasound
  • Hirsutism defined as Ferriman-Gallwey score 8 or higher (5 or higher for Asian women)
  • Acne defined by positive response to having acne
  • Oligomenorrhea defined as menstrual intervals over 35 days and fewer than 8 periods in the past year
  • Amenorrhea defined as fewer than 3 cycles per year
  • Polycystic ovaries defined by ultrasound showing 12 or more follicles sized 2-9 mm or ovarian volume 10 ml or more
  • Willing to sign consent form
Not Eligible

You will not qualify if you...

  • Age over 40 years
  • Other endocrine disorders such as non-classic congenital adrenal hyperplasia, androgen-secreting tumors, or suspected Cushing's syndrome
  • Known kidney disease (creatinine clearance below 60 mL/min), liver failure, autoimmune disorders, or cancer
  • Any acute illness that may affect kidney function or cause tissue hypoxia
  • Type 1 diabetes
  • Use of cortisone, antidepressants, other antidiabetic drugs, hormonal contraceptives, hormonal ovulation induction, or other investigator-judged drugs within 12 weeks (Depo Provera or similar within 6 months)
  • Allergy to metformin or its ingredients
  • Blood pressure higher than 160/100 mmHg
  • Pregnancy or breastfeeding within the past 6 months
  • Acupuncture treatment within the last 2 months
  • Daily smoking and alcohol consumption
  • Language barriers or reduced ability to understand study information

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for eligibility assessment

Treatment

Duration - 4 months

Participants receive lifestyle management instructions at baseline. Those assigned to acupuncture receive treatments three times per week for 4 weeks, then twice per week for 12 weeks. Those assigned to metformin take oral metformin daily with a dose escalation during the first 3 weeks, continuing treatment for a total of 4 months.

Multiple visits for acupuncture treatments or routine follow-up for metformin and lifestyle management

Follow-up

Duration - 4 months

Participants are monitored for another 4 months after treatment ends to assess lasting effects on metabolic, hormonal, and quality of life measures.

Follow-up visits for assessments after treatment completion

Trial Site Locations

Total: 2 locations

1

Peking University

Beijing, China, 100871

Actively Recruiting

2

Karolinska University Hospital

Stockholm, Sweden, 17176

Actively Recruiting

Loading map...

Research Team

E

Elisabet Stener-Victorin, PhD

B

Berit Legerstam, Study nurse

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

A Prospective Cohort Study on the Dynamic Monitoring of Seru...

Polycystic Ovary Syndrome

Actively Recruiting

1 location

Trading Sugar for Sparkles in Adolescents: A Sensory Approac...

Obesity, Adolescent

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial.

Elisabet Stener-Victorin, Haolin Zhang, Rong Li...

https://pubmed.ncbi.nlm.nih.gov/30612112